Robert D. Burk
<p>The main focus of the Burk laboratory is to utilize population-based longitudinal studies from large epidemiological cohorts including those with and without HIV to study the dynamics of host-microbe interactions. These include HPV and development of cancer, and the human microbiome and disease outcomes (cancer, infectious diseases, cardiovascular disease, diabetes, obesity, aging).</p>
<p>To understand complex ecological community of bacteria, fungi, viruses and other organisms and how that might interact for disease outcomes. These studies are built on understanding the application of laboratory tests to population-based studies. They employ NGS and state of the art bioinformatics.</p>
<p>Other interests of the lab include the genetics of complex human disease (prostate cancer, excessive sweating) using large case-control clinical collections of genomic DNAs with candidate gene sequencing; and, the cell biology of VHL and its role in primary cilia formation and activity and its disruption in renal cancer.</p>
<p>The lab is dedicated to creating a warm environment based on collaborative science and teamwork. Our mission is to facilitate each individual reaching his or her potential through learning, experimentation and sharing in the pursuit of knowledge to promote human health and development.</p>
human microbiome;
HPV molecular epidemiology;
HPV molecular evolution;
HPV and cervical cancer;
prostate cancer;
hyperhidrosis
<div>Dr. Burk is an authority on the genomics and evolution of human papillomaviruses (HPV), which cause nearly all cases of cervical cancer. His team was the first to report, in the <em>New England Journal of Medicine</em>, that the vast majority of HPV infections in young women are short-lived and don’t require treatment. More recently, his lab is utilizing Next-Gen sequencing to study papillomavirus genomics and methylation of the viral genome. His lab utilized this new technology to identify HPV16 and beta- and gamma-HPVs associated with head and neck squamous cell cancers (HNSCCs).<br /><br /></div>
<div>Dr. Burk is also currently investigating the role of the human microbiome and cervical HPV natural history. He is a co-PI on a grant with Drs. Kaplan and Rob Knight (UCSD) studying the human gut microbiome and obesity and diabetes. Dr. Burk’s lab has pioneered translational studies of the human microbiome by developing home collection kits that have been used to collect over 5,000 samples.<br /><br /></div>
<div>Dr. Burk was elected in 2015 as a fellow of the American Association for the Advancement of Science (AAAS).</div>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Arial;">(out of 503 published papers; google h-index 126)</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Arial;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Arial;"><span style="font-size: 12pt; text-indent: -27pt; font-family: Arial, sans-serif;">Gradissimo A, Clarke MA, Xue X, Castle PE, Raine-Bennett TR, Schiffman M, Wentzensen N, Strickler HD, Burk RD. A Novel HPV/Host DNA Methylation-Score and Detection of Cervical Adenocarcinoma. J Natl Cancer Inst. 2023. Epub 2023/07/19. doi: 10.1093/jnci/djad134. PMID: 37467068; </span><span style="font-size: 12pt; text-indent: -27pt; font-family: Arial, sans-serif; color: #191919;">PMC1069984</span><span style="font-size: 12pt; text-indent: -27pt; font-family: Arial, sans-serif;">.</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Arial;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Arial;"><span style="font-size: 12pt; font-family: Arial, sans-serif; color: #242424; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Usyk M, Peters B, Karthikeyan S, McDonald D, Sollecito C, Vazquez-Baeza Y, Shaffer J, Gellman M, Talavera G, Daviglus M, Thyagarajan B, K</span><span style="font-size: 12pt; font-family: Arial, sans-serif; color: #242424; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">night R, Qi Q, Kaplan RC, and Burk, R.D. Comprehensive Evaluation of Shotgun Metagenomics, </span><span style="font-size: 12pt; font-family: Arial, sans-serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Amplicon Sequencing and Harmonization of These Platforms for Epidemiological Studies. Cell Report Methods </span><span style="font-size: 12pt; font-family: Arial, sans-serif;">2023 Jan 23;3(1):100391. eCollection 2023 Jan 23. PMID: 36814836; PMC9939430</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Arial;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Arial;"><span style="font-family: Arial, sans-serif; font-size: 12pt;">Schiffman M, Mirabello L, Egemen D, Befano B, Xiao Y, Wentzensen N, Raine-Bennett T, Nayar R, Cheung LC, Rositch A, Beaty T, Perkins RB, de Sanjose S, Lorey T, Castle PE, Burk RD. The combined finding of HPV 16, 18, or 45 and cytologic Atypical Glandular Cells (AGC) indicates a greatly elevated risk of in situ and invasive cervical adenocarcinoma. Gynecol Oncol. 2023;174:253-61. Epub 2023/05/27. doi: 10.1016/j.ygyno.2023.05.011. PMID: 37243996</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Arial;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Arial;"><span style="font-family: Arial, sans-serif; font-size: 12pt;">Burk RD, Mirabello L, DeSalle R. Distinguishing Genetic Drift from Selection in Papillomavirus Evolution. Viruses. 2023;15(8). Epub 2023/08/26. doi: 10.3390/v15081631. PMID: 37631973; PMC10458755.</span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Arial;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Arial;">Usyk M, Schlecht NF, Pickering S, Williams L, Sollecito CC, Gradissimo A, Porras C, Safaeian M, Pinto L, Herrero R, Strickler HD, Viswanathan S, Nucci-Sack A, Diaz A, Burk RD.<em>molBV</em>reveals immune landscape of bacterial vaginosis and predicts human papillomavirus infection natural history. Nat Commun. 2022;13(1):233. Epub 2022/01/13. doi: 10.1038/s41467-021-27628-3. PMID: 35017496; PMC8752746.</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Arial;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Arial;">Schlecht NF, Diaz A, Nucci-Sack A, Shyhalla K, Shankar V, Guillot M, Hollman D, Strickler HD, Burk RD. Incidence and Types of Human Papillomavirus Infections in Adolescent Girls and Young Women Immunized With the Human Papillomavirus Vaccine. JAMA Netw Open. 2021 Aug 2;4(8):e2121893. doi: 10.1001/jamanetworkopen.2021.21893. PMID: 34424304; PMC8383132.</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Arial;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Arial;">Gressel GM, Usyk M, Frimer M, Kuo DYS, Burk RD. Characterization of the endometrial, cervicovaginal and anorectal microbiota in post-menopausal women with endometrioid and serous endometrial cancers. PLoS One. 2021 Nov 5;16(11):e0259188. doi: 10.1371/journal.pone.0259188. PMID: 34739493; PMC8570463.</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Arial;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Arial;">Chen Z, Utro F, Platt D, DeSalle R, Parida L, Chan PKS, Burk RD. K-Mer Analyses Reveal Different Evolutionary Histories of Alpha, Beta, and Gamma Papillomaviruses. Int J Mol Sci. 2021 Sep 6;22(17):9657. doi: 10.3390/ijms22179657. PMID: 34502564; PMC8432194.</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Arial;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Arial;">Kurilshikov, <sup> </sup>A. . . . Burk, R.D. . . . Zhernakova, A. Large-scale association analyses identify host factors influencing human gut microbiome composition. Nat. Genet. 53: 156-165, 2021. doi: 10.1038/s41588-020-00763-1; PMID: 33462485; PMC8515199.</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Arial;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Arial;"><span class="MsoHyperlink" style="color: blue; text-decoration: underline;"><span style="color: windowtext; text-decoration: none;"> </span></span></p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Arial;">Chen, Z., DeSalle, R., Schiffman, M., Herrero, R., Wood, C.E., Ruiz, J.C., Clifford, G.M., Chan, P.K.S. and Burk, R.D. Niche adaptation and viral transmission of human papillomaviruses from archaic hominins to modern humans. PLoS Pathog. 2018, 14(11): e1007352. PMID: 30383862; PMC6211759.</p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Arial;"> </p>
<p class="MsoNormal" style="margin: 0in 0in 0.0001pt; font-size: medium; font-family: Arial;">Mirabello. L., Yeager, M., Yu, K., Clifford, G.M., Xiao, Y., Zhu, B., Cullen, M., Boland, J.F., Wentzensen, N., Nelson, C.W., Raine-Bennett, T., Chen, Z., Bass, S., Song, L., Yang, Q., Steinberg, M., Burdett, L., Dean, M., Roberson, D., Mitchell, J., Lorey, T., Franceschi, S., Castle, P.E., Walker, J., Zuna, R., Kreimer, A.R., Beachler, D.C., Hildesheim, A., Gonzalez, P., Porras, C., Burk, R.D.<strong>* (co-last author)</strong>, Schiffman, M.<strong>*</strong>HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis. Cell. 2017 Sep 7;170(6):1164-1174.PMID: 28886384; PMC5674785</p>
<p>Robert D. Burk, MD, is an attending physician at the Children’s Hospital at Montefiore Einstein. He is Professor and Vice Chair, Translational Research, Pediatrics, Genetic Medicine, and Professor of Microbiology & Immunology; Epidemiology & Population Health; and Obstetrics, Gynecology & Women’s Health at our Albert Einstein College of Medicine. Dr. Burk’s clinical focus centers on cancer genetics and inherited cancer risk.</p><p>After earning his Doctor of Medicine at George Washington University School of Medicine in 1976, Dr. Burk completed a surgical internship at the University of California, San Francisco, in 1977. He remained at this institution to complete his pediatric residency in 1980, followed by a medical genetics fellowship at The Johns Hopkins University School of Medicine in 1983. He then became a Senior Research Fellow in molecular virology and hepatology at the Albert Einstein College of Medicine until 1984.</p><p>Dr. Burk’s research focuses on human papillomavirus (HPV) genomics and its association with cancer and human microbiome studies, investigating the role of the human microbiome in health through large epidemiological studies. His work has been published in numerous peer-reviewed journals and shared through community presentations, media appearances, invited lectures, review articles and book chapters. He is a reviewer for many scientific journals, including the <em>New England Journal of Medicine</em><em>, Hepatology</em> and the <em>Journal of Virology</em>, among others.</p><p>Dr. Burk is a Diplomate of the National Board of Medical Examiners, the American Board of Pediatrics and the American Board of Medical Genetics as a Clinical Geneticist. He is or has been a member of several professional organizations, including the American Society for Microbiology, the American Society of Human Genetics and the Society for Pediatric Research, among others. In 2013, Dr. Burk received the Honorary Alumnus Award and the Saul R. Korey Award in Translational Science & Medicine from the Albert Einstein College of Medicine. In 2015, he became an Elected Fellow of the American Association for the Advancement of Science.</p>